Reslizumab and eosinophilic asthma: One step closer to precision medicine?

G. Varricchi, G. Senna, S. Loffredo, D. Bagnasco, M. Ferrando, G.W. Canonica

Istituto Clinico Humanitas

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Frontiers in Immunology
Volume	8
Issue number	MAR
DOIs	https://doi.org/10.3389/fimmu.2017.00242
Publication status	Published - 2017

Access to Document

10.3389/fimmu.2017.00242

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017211925&doi=10.3389%2ffimmu.2017.00242&partnerID=40&md5=c6b24acace13b5b5349a26eaaa703c09

Cite this

@article{f581a43fc59e4144a9ac08da3d104617,

title = "Reslizumab and eosinophilic asthma: One step closer to precision medicine?",

author = "G. Varricchi and G. Senna and S. Loffredo and D. Bagnasco and M. Ferrando and G.W. Canonica",

year = "2017",

doi = "10.3389/fimmu.2017.00242",

language = "English",

volume = "8",

journal = "Frontiers in Immunology",

issn = "1664-3224",

publisher = "Frontiers Media S.A.",

number = "MAR",

}

TY - JOUR

T1 - Reslizumab and eosinophilic asthma: One step closer to precision medicine?

AU - Varricchi, G.

AU - Senna, G.

AU - Loffredo, S.

AU - Bagnasco, D.

AU - Ferrando, M.

AU - Canonica, G.W.

PY - 2017

Y1 - 2017

U2 - 10.3389/fimmu.2017.00242

DO - 10.3389/fimmu.2017.00242

M3 - Article

C2 - 28344579

VL - 8

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

IS - MAR

ER -